ACADM and glioma: LC/MS-based analyses of glioma sphere-forming cells (GSCs) were conducted to investigate the impact of medium-chain acyl-CoA dehydrogenase (MCAD) deletion on cellular lipids and demonstrated that MCAD deletion significantly elevated the levels of triacylglycerol (TAG) and certain phospholipids [14].